+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Bacterial Disease Diagnostics Market 2023-2027

  • PDF Icon

    Report

  • 165 Pages
  • February 2023
  • Region: Global
  • TechNavio
  • ID: 5563113
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bacterial disease diagnostics market is forecasted to grow by $3766.05 mn during 2022-2027, decelerating at a CAGR of 6.28% during the forecast period. The report on the bacterial disease diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by integration of digital health in rapid diagnostics for bacterial disease, high prevalence of infectious diseases, and growing number of merger and acquisition (M&A) activities.

The bacterial disease diagnostics market is segmented as below:

By Product

  • Consumables
  • Instruments

By End-user

  • Hospitals
  • Labs

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing demand for portable analytical instruments as one of the prime reasons driving the bacterial disease diagnostics market growth during the next few years. Also, increasing number of partnerships and collaborations and clinical developments will lead to sizable demand in the market.

The report on the bacterial disease diagnostics market covers the following areas:

  • Bacterial disease diagnostics market sizing
  • Bacterial disease diagnostics market forecast
  • Bacterial disease diagnostics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bacterial disease diagnostics market vendors that include Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., GENERI BIOTECH s.r.o., Great Basin Scientific, Hologic Inc., Meridian Bioscience Inc., Perkin Elmer Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, T2 Biosystems Inc., and Takara Bio Inc. Also, the bacterial disease diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global bacterial disease diagnostics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global bacterial disease diagnostics market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Consumables - Market size and forecast 2022-2027
Exhibit 34: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Consumables - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
6.4 Instruments - Market size and forecast 2022-2027
Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)

7 Market Segmentation by End-user
7.1 Market segments
Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 45: Chart on Comparison by End-user
Exhibit 46: Data Table on Comparison by End-user
7.3 Hospitals - Market size and forecast 2022-2027
Exhibit 47: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
7.4 Labs - Market size and forecast 2022-2027
Exhibit 51: Chart on Labs - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Labs - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Labs - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Labs - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by End-user
Exhibit 55: Market opportunity by End-user ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 57: Chart on Market share by geography 2022-2027 (%)
Exhibit 58: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 59: Chart on Geographic comparison
Exhibit 60: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Canada - Market size and forecast 2022-2027
Exhibit 81: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 89: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 93: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 97: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 98: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 100: Overview on factors of disruption
11.4 Industry risks
Exhibit 101: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 102: Vendors covered
12.2 Market positioning of vendors
Exhibit 103: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 104: Abbott Laboratories - Overview
Exhibit 105: Abbott Laboratories - Business segments
Exhibit 106: Abbott Laboratories - Key news
Exhibit 107: Abbott Laboratories - Key offerings
Exhibit 108: Abbott Laboratories - Segment focus
12.4 Accelerate Diagnostics Inc.
Exhibit 109: Accelerate Diagnostics Inc. - Overview
Exhibit 110: Accelerate Diagnostics Inc. - Product/Service
Exhibit 111: Accelerate Diagnostics Inc. - Key offerings
12.5 Becton Dickinson and Co.
Exhibit 112: Becton Dickinson and Co. - Overview
Exhibit 113: Becton Dickinson and Co. - Business segments
Exhibit 114: Becton Dickinson and Co. - Key news
Exhibit 115: Becton Dickinson and Co. - Key offerings
Exhibit 116: Becton Dickinson and Co. - Segment focus
12.6 Bio Rad Laboratories Inc.
Exhibit 117: Bio Rad Laboratories Inc. - Overview
Exhibit 118: Bio Rad Laboratories Inc. - Business segments
Exhibit 119: Bio Rad Laboratories Inc. - Key news
Exhibit 120: Bio Rad Laboratories Inc. - Key offerings
Exhibit 121: Bio Rad Laboratories Inc. - Segment focus
12.7 bioMerieux SA
Exhibit 122: bioMerieux SA - Overview
Exhibit 123: bioMerieux SA - Product/Service
Exhibit 124: bioMerieux SA - Key offerings
12.8 Danaher Corp.
Exhibit 125: Danaher Corp. - Overview
Exhibit 126: Danaher Corp. - Business segments
Exhibit 127: Danaher Corp. - Key news
Exhibit 128: Danaher Corp. - Key offerings
Exhibit 129: Danaher Corp. - Segment focus
12.9 DiaSorin SpA
Exhibit 130: DiaSorin SpA - Overview
Exhibit 131: DiaSorin SpA - Business segments
Exhibit 132: DiaSorin SpA - Key news
Exhibit 133: DiaSorin SpA - Key offerings
Exhibit 134: DiaSorin SpA - Segment focus
12.10 EKF Diagnostics Holdings Plc
Exhibit 135: EKF Diagnostics Holdings Plc - Overview
Exhibit 136: EKF Diagnostics Holdings Plc - Business segments
Exhibit 137: EKF Diagnostics Holdings Plc - Key offerings
Exhibit 138: EKF Diagnostics Holdings Plc - Segment focus
12.11 F. Hoffmann La Roche Ltd.
Exhibit 139: F. Hoffmann La Roche Ltd. - Overview
Exhibit 140: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 141: F. Hoffmann La Roche Ltd. - Key news
Exhibit 142: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 143: F. Hoffmann La Roche Ltd. - Segment focus
12.12 Hologic Inc.
Exhibit 144: Hologic Inc. - Overview
Exhibit 145: Hologic Inc. - Business segments
Exhibit 146: Hologic Inc. - Key news
Exhibit 147: Hologic Inc. - Key offerings
Exhibit 148: Hologic Inc. - Segment focus
12.13 Perkin Elmer Inc.
Exhibit 149: Perkin Elmer Inc. - Overview
Exhibit 150: Perkin Elmer Inc. - Business segments
Exhibit 151: Perkin Elmer Inc. - Key news
Exhibit 152: Perkin Elmer Inc. - Key offerings
Exhibit 153: Perkin Elmer Inc. - Segment focus
12.14 QIAGEN NV
Exhibit 154: QIAGEN NV - Overview
Exhibit 155: QIAGEN NV - Product/Service
Exhibit 156: QIAGEN NV - Key news
Exhibit 157: QIAGEN NV - Key offerings
12.15 Quest Diagnostics Inc.
Exhibit 158: Quest Diagnostics Inc. - Overview
Exhibit 159: Quest Diagnostics Inc. - Business segments
Exhibit 160: Quest Diagnostics Inc. - Key offerings
Exhibit 161: Quest Diagnostics Inc. - Segment focus
12.16 Siemens AG
Exhibit 162: Siemens AG - Overview
Exhibit 163: Siemens AG - Business segments
Exhibit 164: Siemens AG - Key news
Exhibit 165: Siemens AG - Key offerings
Exhibit 166: Siemens AG - Segment focus
12.17 Takara Bio Inc.
Exhibit 167: Takara Bio Inc. - Overview
Exhibit 168: Takara Bio Inc. - Business segments
Exhibit 169: Takara Bio Inc. - Key offerings
Exhibit 170: Takara Bio Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 171: Inclusions checklist
Exhibit 172: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 173: Currency conversion rates for US$
13.4 Research methodology
Exhibit 174: Research methodology
Exhibit 175: Validation techniques employed for market sizing
Exhibit 176: Information sources
13.5 List of abbreviations
Exhibit 177: List of abbreviations

List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global bacterial disease diagnostics market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Product - Market share 2022-2027 (%)
Exhibits 31: Data Table on Product - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Consumables - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Product ($ million)
Exhibits 43: Chart on End-user - Market share 2022-2027 (%)
Exhibits 44: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 45: Chart on Comparison by End-user
Exhibits 46: Data Table on Comparison by End-user
Exhibits 47: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 50: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 51: Chart on Labs - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Data Table on Labs - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Chart on Labs - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on Labs - Year-over-year growth 2022-2027 (%)
Exhibits 55: Market opportunity by End-user ($ million)
Exhibits 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 57: Chart on Market share by geography 2022-2027 (%)
Exhibits 58: Data Table on Market share by geography 2022-2027 (%)
Exhibits 59: Chart on Geographic comparison
Exhibits 60: Data Table on Geographic comparison
Exhibits 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 63: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 77: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 82: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 94: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 95: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 97: Market opportunity by geography ($ million)
Exhibits 98: Impact of drivers and challenges in 2022 and 2027
Exhibits 99: Overview on Criticality of inputs and Factors of differentiation
Exhibits 100: Overview on factors of disruption
Exhibits 101: Impact of key risks on business
Exhibits 102: Vendors covered
Exhibits 103: Matrix on vendor position and classification
Exhibits 104: Abbott Laboratories - Overview
Exhibits 105: Abbott Laboratories - Business segments
Exhibits 106: Abbott Laboratories - Key news
Exhibits 107: Abbott Laboratories - Key offerings
Exhibits 108: Abbott Laboratories - Segment focus
Exhibits 109: Accelerate Diagnostics Inc. - Overview
Exhibits 110: Accelerate Diagnostics Inc. - Product/Service
Exhibits 111: Accelerate Diagnostics Inc. - Key offerings
Exhibits 112: Becton Dickinson and Co. - Overview
Exhibits 113: Becton Dickinson and Co. - Business segments
Exhibits 114: Becton Dickinson and Co. - Key news
Exhibits 115: Becton Dickinson and Co. - Key offerings
Exhibits 116: Becton Dickinson and Co. - Segment focus
Exhibits 117: Bio Rad Laboratories Inc. - Overview
Exhibits 118: Bio Rad Laboratories Inc. - Business segments
Exhibits 119: Bio Rad Laboratories Inc. - Key news
Exhibits 120: Bio Rad Laboratories Inc. - Key offerings
Exhibits 121: Bio Rad Laboratories Inc. - Segment focus
Exhibits 122: bioMerieux SA - Overview
Exhibits 123: bioMerieux SA - Product/Service
Exhibits 124: bioMerieux SA - Key offerings
Exhibits 125: Danaher Corp. - Overview
Exhibits 126: Danaher Corp. - Business segments
Exhibits 127: Danaher Corp. - Key news
Exhibits 128: Danaher Corp. - Key offerings
Exhibits 129: Danaher Corp. - Segment focus
Exhibits 130: DiaSorin SpA - Overview
Exhibits 131: DiaSorin SpA - Business segments
Exhibits 132: DiaSorin SpA - Key news
Exhibits 133: DiaSorin SpA - Key offerings
Exhibits 134: DiaSorin SpA - Segment focus
Exhibits 135: EKF Diagnostics Holdings Plc - Overview
Exhibits 136: EKF Diagnostics Holdings Plc - Business segments
Exhibits 137: EKF Diagnostics Holdings Plc - Key offerings
Exhibits 138: EKF Diagnostics Holdings Plc - Segment focus
Exhibits 139: F. Hoffmann La Roche Ltd. - Overview
Exhibits 140: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 141: F. Hoffmann La Roche Ltd. - Key news
Exhibits 142: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 143: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 144: Hologic Inc. - Overview
Exhibits 145: Hologic Inc. - Business segments
Exhibits 146: Hologic Inc. - Key news
Exhibits 147: Hologic Inc. - Key offerings
Exhibits 148: Hologic Inc. - Segment focus
Exhibits 149: Perkin Elmer Inc. - Overview
Exhibits 150: Perkin Elmer Inc. - Business segments
Exhibits 151: Perkin Elmer Inc. - Key news
Exhibits 152: Perkin Elmer Inc. - Key offerings
Exhibits 153: Perkin Elmer Inc. - Segment focus
Exhibits 154: QIAGEN NV - Overview
Exhibits 155: QIAGEN NV - Product/Service
Exhibits 156: QIAGEN NV - Key news
Exhibits 157: QIAGEN NV - Key offerings
Exhibits 158: Quest Diagnostics Inc. - Overview
Exhibits 159: Quest Diagnostics Inc. - Business segments
Exhibits 160: Quest Diagnostics Inc. - Key offerings
Exhibits 161: Quest Diagnostics Inc. - Segment focus
Exhibits 162: Siemens AG - Overview
Exhibits 163: Siemens AG - Business segments
Exhibits 164: Siemens AG - Key news
Exhibits 165: Siemens AG - Key offerings
Exhibits 166: Siemens AG - Segment focus
Exhibits 167: Takara Bio Inc. - Overview
Exhibits 168: Takara Bio Inc. - Business segments
Exhibits 169: Takara Bio Inc. - Key offerings
Exhibits 170: Takara Bio Inc. - Segment focus
Exhibits 171: Inclusions checklist
Exhibits 172: Exclusions checklist
Exhibits 173: Currency conversion rates for US$
Exhibits 174: Research methodology
Exhibits 175: Validation techniques employed for market sizing
Exhibits 176: Information sources
Exhibits 177: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global bacterial disease diagnostics market: Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., GENERI BIOTECH s.r.o., Great Basin Scientific, Hologic Inc., Meridian Bioscience Inc., Perkin Elmer Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, T2 Biosystems Inc., and Takara Bio Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is growing demand for portable analytical instruments.`

According to the report, one of the major drivers for this market is the integration of digital health in rapid diagnostics for bacterial disease.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Accelerate Diagnostics Inc.
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • bioMerieux SA
  • Bruker Corp.
  • Danaher Corp.
  • DiaSorin SpA
  • EKF Diagnostics Holdings Plc
  • F. Hoffmann La Roche Ltd.
  • GENERI BIOTECH s.r.o.
  • Great Basin Scientific
  • Hologic Inc.
  • Meridian Bioscience Inc.
  • Perkin Elmer Inc.
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Siemens AG
  • T2 Biosystems Inc.
  • Takara Bio Inc.